These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2884936)

  • 21. Sulphasalazine in rheumatoid arthritis: an old drug revived.
    Neumann VC; Grindulis KA
    J R Soc Med; 1984 Mar; 77(3):169-72. PubMed ID: 6142116
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulphasalazine in rheumatoid arthritis.
    Boey ML; Lee E; Feng PH
    Singapore Med J; 1988 Jun; 29(3):285-8. PubMed ID: 2903555
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
    Walker EM; Carty JE
    Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.
    Situnayake RD; McConkey B
    Drugs; 1986; 32 Suppl 1():71-2. PubMed ID: 2877857
    [No Abstract]   [Full Text] [Related]  

  • 26. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.
    Farr M; Symmons DP; Bacon PA
    Ann Rheum Dis; 1985 Nov; 44(11):798-800. PubMed ID: 2865931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.
    Delamere JP; Farr M; Grindulis KA
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1547-8. PubMed ID: 6133577
    [No Abstract]   [Full Text] [Related]  

  • 28. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.
    Prouse PJ; Shawe D; Gumpel JM
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1407. PubMed ID: 2879599
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.
    Farr M; Tunn E; Bacon PA; Smith DH
    Ann Rheum Dis; 1985 Oct; 44(10):723-4. PubMed ID: 2864899
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
    Capell HA; Pullar T; Hunter JA
    Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulphasalazine hepatotoxicity: lack of a hypersensitivity response.
    MacGilchrist AJ; Hunter JA
    Ann Rheum Dis; 1986 Nov; 45(11):967-8. PubMed ID: 2878646
    [No Abstract]   [Full Text] [Related]  

  • 34. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
    Amos RS; Pullar T; Bax DE; Situnayake D; Capell HA; McConkey B
    Br Med J (Clin Res Ed); 1986 Aug; 293(6544):420-3. PubMed ID: 2874863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
    Wijnands MJ; Van 'T Hof MA; Van De Putte LB; Van Riel PL
    Br J Rheumatol; 1993 Apr; 32(4):313-8. PubMed ID: 8096419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets].
    Amos RS
    Z Rheumatol; 1987; 46(2):76-8. PubMed ID: 2885988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylation, sulphasalazine and its effects.
    Astbury C; Taggart AJ
    Br J Rheumatol; 1987 Jun; 26(3):229-30. PubMed ID: 2884010
    [No Abstract]   [Full Text] [Related]  

  • 40. Leucopenia during sulphasalazine treatment for rheumatoid arthritis.
    Marabani M; Madhok R; Capell HA; Hunter JA
    Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.